1. Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes
- Author
-
Xiao-Xi Zhang, Yin-Ling Chen, Yong-Chao Qiao, Li Wan, Qin-yuan Liao, Qiu-jin Zhang, Jian Shen, Xia Zou, He Lan, and Hai-Lu Zhao
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Immunology ,Amylin ,Spleen ,Nod ,T-Lymphocytes, Regulatory ,Peripheral blood mononuclear cell ,Immunomodulation ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Mice, Inbred NOD ,Transforming Growth Factor beta ,Insulin-Secreting Cells ,Internal medicine ,medicine ,Animals ,Humans ,Cells, Cultured ,NOD mice ,biology ,business.industry ,FOXP3 ,Forkhead Transcription Factors ,Transforming growth factor beta ,medicine.disease ,Islet Amyloid Polypeptide ,Toll-Like Receptor 4 ,Diabetes Mellitus, Type 1 ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,CD4 Antigens ,biology.protein ,business ,Insulitis - Abstract
Autoimmune diabetes is a disorder of immune homeostasis that leads to targeted insulin-secreting islet β cell destruction characterized by insulitis. Human amylin (hA) is an important neuroendocrine hormone co-secreted with insulin by pancreatic β cells. Here, we report hA immune-modulatory action through inducing regulatory T cells. We ex vivo-treated human peripheral blood mononuclear cells (hPBMCs) with hA for 24 h and counted CD4+Foxp3+ regulatory T cells (Treg) using flow cytometry. Diabetic status was monitored and splenic Treg were measured in non-obese diabetic (NOD) male mice. NOD mice were intraperitoneally injected once daily with hA (n = 25) or solvent for control (n = 25) for 7 months continuously. Spleen tissues were collected at the end of intervention and processed for flow cytometry and Western blot. We found a 2.9-fold (p
- Published
- 2017